Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Sold as Decadron, Dexacort, Hexadrol. Every FDA application for this active ingredient: 7 branded and 50 generic.
As of Nov 16, 2026, FDA lists 57 applications for Dexamethasone Sodium Phosphate (sold as Decadron, Dexacort, Hexadrol), first approved Aug 26, 1959, with 0 new uses approved and 0 published complete response letters.
First approved: Aug 26, 1959
Applications: 57
New uses approved: 0
Complete response letters: 0
First approved in the EU: Jul 26, 2010
Shortage: Current
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
DEXAMETHASONE 0.1% EYE DROP: $8.31 per MLGeneric · +5% in a year
DEXAMETHASONE 0.5 MG TABLET: $0.071 per unitGeneric · -23% in a year
DEXAMETHASONE 0.5 MG/5 ML ELX: $0.104 per MLGeneric · +4% in a year
DEXAMETHASONE 0.5 MG/5 ML LIQ: $0.100 per MLGeneric · +11% in a year
DEXAMETHASONE 0.75 MG TABLET: $0.091 per unitGeneric · -28% in a year
DEXAMETHASONE 1 MG TABLET: $0.148 per unitGeneric · -12% in a year
DEXAMETHASONE 1.5 MG TABLET: $0.181 per unitGeneric · -42% in a year
DEXAMETHASONE 10 MG/ML VIAL: $1.26 per MLGeneric · +5% in a year
DEXAMETHASONE 100 MG/10 ML VL: $0.510 per MLGeneric · -44% in a year
DEXAMETHASONE 120 MG/30 ML VL: $0.701 per MLGeneric · +22% in a year
DEXAMETHASONE 2 MG TABLET: $0.260 per unitGeneric · -23% in a year
DEXAMETHASONE 20 MG/5 ML VIAL: $0.238 per MLGeneric · +53% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA